Cancer Advances and Biopharma Cutbacks

Kilder

• STAT: STAT+: One of the most consequential years for cancer treatment, ever
• STAT: FDA approves Ultragenyx gene therapy - STAT
• STAT: STAT+: FDA approves Ultragenyx gene therapy
• Raps: Recon: FDA approves Ultragenyx gene therapy for glycogen storage disorder; Overton faces confirmation challenges - RAPS
• STAT: STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection
• STAT: FDA approves Ultragenyx gene therapy - STAT
• BioSpace: 7 biopharma M&A deals where layoffs followed
• BioSpace: Out of sight, out of work? What’s driving remote job cuts
• wikimedia: Photo by Michael C. Milone & Una O’Doherty / Wikimedia Commons / CC BY 4.0

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.